Clinical Trial Update: A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cobimetinib plus atezolizumab and atezolizumab alone versus regorafenib in metastatic colorectal adenocarcinoma; study completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Cobimetinib (cobimetinib)
• Regorafenib (regorafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-06-18